₹107.1*
MRP ₹119
10% off
₹101.15*
MRP ₹119
15% CB
₹17.85 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Available Offers
PHARMA1818% OFF, applicable on orders > INR 2999
PHARMA1010% OFF, applicable on orders > INR 799
PHARMA2020% OFF, applicable on orders > INR 5499
Prescription drugWhats That
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Extra Savings
Composition :
AZILSARTAN-40MG + CHLORTHALIDONE-6.25MG
Manufacturer/Marketer :
Micro Labs Ltd
Consume Type :
ORAL
Return Policy :
Not Returnable
Expires on or after :
Jan-27
Drug-Drug Interactions
chlorthalidoneCisapride
Critical
Azilsartan medoxomilAliskiren
Critical
Drug-Drug Interactions
Login/Sign Up
chlorthalidoneCisapride
Critical
How does the drug interact with Zilarta-CT 40/6.25 Tablet:
Co-administration of Zilarta-CT 40/6.25 Tablet and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking Zilarta-CT 40/6.25 Tablet with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
Co-administration of Zilarta-CT 40/6.25 Tablet and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking Zilarta-CT 40/6.25 Tablet with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
Azilsartan medoxomilAliskiren
Critical
How does the drug interact with Zilarta-CT 40/6.25 Tablet:
Taking Aliskiren with Zilarta-CT 40/6.25 Tablet can increase the risk of low blood pressure and high potassium levels in the body.
How to manage the interaction:
Taking Zilarta-CT 40/6.25 Tablet with Aliskiren is generally avoided as it may lead to an interaction, it can be taken if prescribed by the doctor. Consult the doctor if you experience vomiting, weakness, tingling in your hands and feet, or palpitations. Make sure to hydrate while taking these medications. It is advised to reduce the intake of potassium-rich foods. Do not discontinue any medications without a doctor's advice.
Taking Aliskiren with Zilarta-CT 40/6.25 Tablet can increase the risk of low blood pressure and high potassium levels in the body.
How to manage the interaction:
Taking Zilarta-CT 40/6.25 Tablet with Aliskiren is generally avoided as it may lead to an interaction, it can be taken if prescribed by the doctor. Consult the doctor if you experience vomiting, weakness, tingling in your hands and feet, or palpitations. Make sure to hydrate while taking these medications. It is advised to reduce the intake of potassium-rich foods. Do not discontinue any medications without a doctor's advice.
chlorthalidoneZiprasidone
Severe
How does the drug interact with Zilarta-CT 40/6.25 Tablet:
Co-administration of Zilarta-CT 40/6.25 Tablet with ziprasidone can increase the risk of an irregular heart rhythm that may be serious.
How to manage the interaction:
Although there is an interaction, Zilarta-CT 40/6.25 Tablet can be taken with ziprasidone if prescribed by the doctor. but it can be taken together if prescribed by a doctor. However, consult your doctor if you experience sudden dizziness, lightheadedness, fainting, shortness of breath, weakness, tiredness, drowsiness, confusion, muscle pain, cramps, nausea, or vomiting. Do not discontinue any medications without consulting a doctor.
Co-administration of Zilarta-CT 40/6.25 Tablet with ziprasidone can increase the risk of an irregular heart rhythm that may be serious.
How to manage the interaction:
Although there is an interaction, Zilarta-CT 40/6.25 Tablet can be taken with ziprasidone if prescribed by the doctor. but it can be taken together if prescribed by a doctor. However, consult your doctor if you experience sudden dizziness, lightheadedness, fainting, shortness of breath, weakness, tiredness, drowsiness, confusion, muscle pain, cramps, nausea, or vomiting. Do not discontinue any medications without consulting a doctor.
chlorthalidoneTizanidine
Severe
How does the drug interact with Zilarta-CT 40/6.25 Tablet:
Co-administration of Tizanidine and Zilarta-CT 40/6.25 Tablet may show additive effects and increase the risk of low blood pressure.
How to manage the interaction:
Although there is an interaction, Zilarta-CT 40/6.25 Tablet can be taken with tizanidine if prescribed by the doctor. If you experience headache, dizziness, palpitations, or sweating, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
Co-administration of Tizanidine and Zilarta-CT 40/6.25 Tablet may show additive effects and increase the risk of low blood pressure.
How to manage the interaction:
Although there is an interaction, Zilarta-CT 40/6.25 Tablet can be taken with tizanidine if prescribed by the doctor. If you experience headache, dizziness, palpitations, or sweating, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
chlorthalidoneArsenic trioxide
Severe
How does the drug interact with Zilarta-CT 40/6.25 Tablet:
Taking Zilarta-CT 40/6.25 Tablet can make the body eliminate Arsenic trioxide faster, leading to lower levels in the blood and potentially reducing its effectiveness.
How to manage the interaction:
Co-administration of Zilarta-CT 40/6.25 Tablet with Arsenic trioxide can possibly result in an interaction, but it can be taken if a doctor has advised it. If you have any of these symptoms, it's important to contact a doctor right away: your heart beating irregularly, feeling dizzy or lightheaded, fainting, having a fast or pounding heartbeat, feeling weak or drowsy, being confused, experiencing muscle pain, or feeling nauseous or vomiting. Do not discontinue any medications without consulting a doctor.
Taking Zilarta-CT 40/6.25 Tablet can make the body eliminate Arsenic trioxide faster, leading to lower levels in the blood and potentially reducing its effectiveness.
How to manage the interaction:
Co-administration of Zilarta-CT 40/6.25 Tablet with Arsenic trioxide can possibly result in an interaction, but it can be taken if a doctor has advised it. If you have any of these symptoms, it's important to contact a doctor right away: your heart beating irregularly, feeling dizzy or lightheaded, fainting, having a fast or pounding heartbeat, feeling weak or drowsy, being confused, experiencing muscle pain, or feeling nauseous or vomiting. Do not discontinue any medications without consulting a doctor.
chlorthalidoneLithium
Severe
How does the drug interact with Zilarta-CT 40/6.25 Tablet:
Co-administration of Zilarta-CT 40/6.25 Tablet together with lithium can increase the effects of lithium.
How to manage the interaction:
Although there is a interaction between Zilarta-CT 40/6.25 Tablet and lithium, but it can be taken together if prescribed by a doctor. However, consult your doctor if you experience diarrhea, vomiting, drowsiness, shaking of hands and legs, thirst, increased urination, lack of coordination, or muscle weakness. Do not discontinue any medications without consulting a doctor.
Co-administration of Zilarta-CT 40/6.25 Tablet together with lithium can increase the effects of lithium.
How to manage the interaction:
Although there is a interaction between Zilarta-CT 40/6.25 Tablet and lithium, but it can be taken together if prescribed by a doctor. However, consult your doctor if you experience diarrhea, vomiting, drowsiness, shaking of hands and legs, thirst, increased urination, lack of coordination, or muscle weakness. Do not discontinue any medications without consulting a doctor.
chlorthalidoneDroperidol
Severe
How does the drug interact with Zilarta-CT 40/6.25 Tablet:
Taking Droperidol can make Zilarta-CT 40/6.25 Tablet less effective in lowering blood pressure.
How to manage the interaction:
Taking Zilarta-CT 40/6.25 Tablet with Droperidol together can possibly result in an interaction, but it can be taken if your doctor has advised it. If you have any of these symptoms, it's important to contact your doctor right away. These symptoms include an irregular heart rhythm, severe or long-lasting diarrhea or vomiting, complications, sudden dizziness or lightheadedness, fainting, difficulty breathing, heart palpitations, weakness, feeling sleepy or confused, muscle pain, and feeling nauseous or vomiting. Do not stop using any medications without first talking to your doctor.
Taking Droperidol can make Zilarta-CT 40/6.25 Tablet less effective in lowering blood pressure.
How to manage the interaction:
Taking Zilarta-CT 40/6.25 Tablet with Droperidol together can possibly result in an interaction, but it can be taken if your doctor has advised it. If you have any of these symptoms, it's important to contact your doctor right away. These symptoms include an irregular heart rhythm, severe or long-lasting diarrhea or vomiting, complications, sudden dizziness or lightheadedness, fainting, difficulty breathing, heart palpitations, weakness, feeling sleepy or confused, muscle pain, and feeling nauseous or vomiting. Do not stop using any medications without first talking to your doctor.
chlorthalidonePimozide
Severe
How does the drug interact with Zilarta-CT 40/6.25 Tablet:
Co-administration of Zilarta-CT 40/6.25 Tablet with pimozide can increase the risk of an irregular heart rhythm that may be serious.
How to manage the interaction:
Although there is an interaction, Zilarta-CT 40/6.25 Tablet can be taken with pimozide if prescribed by the doctor. Consult the prescriber if you develop sudden dizziness, lightheadedness, fainting, or fast or pounding heartbeats during treatment with pimozide. Also, let the doctor know if you experience signs of electrolyte disturbance, such as weakness, tiredness, drowsiness, confusion, muscle pain, cramps, dizziness, nausea, or vomiting. Do not discontinue any medications without consulting a doctor.
Co-administration of Zilarta-CT 40/6.25 Tablet with pimozide can increase the risk of an irregular heart rhythm that may be serious.
How to manage the interaction:
Although there is an interaction, Zilarta-CT 40/6.25 Tablet can be taken with pimozide if prescribed by the doctor. Consult the prescriber if you develop sudden dizziness, lightheadedness, fainting, or fast or pounding heartbeats during treatment with pimozide. Also, let the doctor know if you experience signs of electrolyte disturbance, such as weakness, tiredness, drowsiness, confusion, muscle pain, cramps, dizziness, nausea, or vomiting. Do not discontinue any medications without consulting a doctor.
chlorthalidoneAmiodarone
Severe
How does the drug interact with Zilarta-CT 40/6.25 Tablet:
Coadministration of Zilarta-CT 40/6.25 Tablet with amiodarone may increase the risk of abnormal heart rhythms.
How to manage the interaction:
Although taking Zilarta-CT 40/6.25 Tablet with amiodarone may cause an interaction, it is safe to do so if your doctor has prescribed it. If you have a cardiac problem or electrolyte imbalances, you may be more vulnerable. If you develop sudden dizziness, lightheadedness, fainting, shortness of breath, or a rapid heartbeat, consult a doctor. Do not stop taking any medications without visiting a doctor.
Coadministration of Zilarta-CT 40/6.25 Tablet with amiodarone may increase the risk of abnormal heart rhythms.
How to manage the interaction:
Although taking Zilarta-CT 40/6.25 Tablet with amiodarone may cause an interaction, it is safe to do so if your doctor has prescribed it. If you have a cardiac problem or electrolyte imbalances, you may be more vulnerable. If you develop sudden dizziness, lightheadedness, fainting, shortness of breath, or a rapid heartbeat, consult a doctor. Do not stop taking any medications without visiting a doctor.
chlorthalidoneAminolevulinic acid
Severe
How does the drug interact with Zilarta-CT 40/6.25 Tablet:
Co-administration of Aminolevulinic acid and Zilarta-CT 40/6.25 Tablet may increase the risk of severe sunburn.
How to manage the interaction:
Taking Zilarta-CT 40/6.25 Tablet with Aminolevulinic acid together can possibly result in an interaction, but it can be taken if a doctor has advised it. If you notice that your skin is very sensitive to sunlight or if you have a really bad sunburn, it's important to contact your doctor right away. Do not discontinue any medications without consulting a doctor.
Co-administration of Aminolevulinic acid and Zilarta-CT 40/6.25 Tablet may increase the risk of severe sunburn.
How to manage the interaction:
Taking Zilarta-CT 40/6.25 Tablet with Aminolevulinic acid together can possibly result in an interaction, but it can be taken if a doctor has advised it. If you notice that your skin is very sensitive to sunlight or if you have a really bad sunburn, it's important to contact your doctor right away. Do not discontinue any medications without consulting a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Alcohol
Caution
Avoid alcohol consumption with Zilarta-CT 40/6.25 Tablet as it may cause increased dizziness.
Pregnancy
Caution
Zilarta-CT 40/6.25 Tablet is not recommended for use during pregnancy since it may harm the baby. Consult your doctor before taking the Zilarta-CT 40/6.25 Tablet if you plan to become pregnant or are already pregnant.
Breast Feeding
Caution
Please consult your doctor before taking Zilarta-CT 40/6.25 Tablet if you are breastfeeding. Your doctor will decide if Zilarta-CT 40/6.25 Tablet can be taken during lactation or not.
Driving
Caution
Zilarta-CT 40/6.25 Tablet may cause side effects like dizziness or tiredness. Hence, it is recommended not to drive or operate machinery until you are alert.
Liver
Caution
Let your doctor know if you have/had the liver disease before taking Zilarta-CT 40/6.25 Tablet . Your doctor may adjust the dose accordingly.
Kidney
Caution
Let your doctor know if you have/had kidney disease before taking the Zilarta-CT 40/6.25 Tablet . Your doctor may adjust the dose accordingly.
Children
Unsafe
Safety and efficacy of Zilarta-CT 40/6.25 Tablet have not been established in children.
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
